Trials / Completed
CompletedNCT05449847
Plasma MicroRNA for Prediction of Hepatocellular Carcinoma
Plasma Expression Levels of MicroRNA-21 Might Help for Detection of HCV Patients Complicated by Hepatocellular Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Benha University · Academic / Other
- Sex
- All
- Age
- 31 Years – 67 Years
- Healthy volunteers
- Not accepted
Summary
100 patients with diagnosed HCV were evaluated by clinical and ultrasound examination and were categorized as uncomplicated HCV (n=22) and complicated HCV (n=78). All patients were evaluated for hepatosteatosis and liver fibrosis using the computerized hepatorenal index, the hepatic steatosis index, aspartate aminotransferase (AST)/platelet count index (APRI) and the Fibrosis-4 (FIB-4) scores. Blood samples were obtained for estimation of serum levels of liver function tests and plasma levels of microRNA 21 and 126.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood Sampling | Blood sampling under a complete aseptic conditions |
Timeline
- Start date
- 2021-05-13
- Primary completion
- 2021-12-07
- Completion
- 2022-03-20
- First posted
- 2022-07-08
- Last updated
- 2022-07-08
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05449847. Inclusion in this directory is not an endorsement.